Resources are provided for educational purposes and may include primary research, government documents, professional statements, legal opinions, and other materials representing differing types and levels of evidence. Inclusion does not necessarily constitute endorsement of every conclusion or interpretation contained in a source. Readers are encouraged to review original materials, consider study design and limitations, and discuss individual medical decisions with a qualified healthcare professional. This resource guide does not provide medical or legal advice.
Use the Type and Topic filters on their own or together. Click a selected filter again, or choose All, to clear it.
Type
Topic
Psychiatric Morbidity Among Adolescents and Young Adults Who Contacted Specialised Gender Identity Services in Finland in 1996-2019: A Register Study
Cohort Study
Sami-Matti Ruuska, Katinka Tuisku, Timo Holttinen, Riittakerttu Kaltiala
Acta Paediatrica
Published April 4, 2026
DOI: 10.1111/apa.70533
2,083 individuals referred to specialized gender identity services before age 23 and 16,643 matched population controls in Finland
Pediatric Gender Medicine | Gender Dysphoria | Psychiatric Morbidity | Mental Health | Gender Reassignment
Reanalysis of FDA Clinical Data for mFLUSIVA (mRNA-1010): Unfavorable Risk-Benefit Profile Supports Market Withdrawal
Secondary Data Reanalysis
Nicolas Hulscher, Peter A. McCullough, John A. Catanzaro
Zenodo
Published August 19, 2026
DOI: 10.5281/zenodo.22016811
mRNA Influenza Vaccine | mFLUSIVA | Vaccine Safety | Risk-Benefit Analysis | FDA
Calls for Market Removal of COVID-19 Vaccines Intensify as Risks Far Outweigh Theoretical Benefits
Narrative Review and Policy Analysis
Nicolas Hulscher, Mary T. Bowden, Peter A. McCullough
Science, Public Health Policy and the Law
Published January 28, 2025
COVID-19 Vaccines | Vaccine Safety | Pharmacovigilance | Excess Mortality | Regulatory Policy
Booster Vaccination with SARS-CoV-2 mRNA Vaccines and Myocarditis in Adolescents and Young Adults: A Nordic Cohort Study
Cohort Study
Hviid A, Nieminen TA, Pihlström N, et al.
European Heart Journal
Published 2024
COVID-19 Vaccines | Booster Doses | Myocarditis | Adolescents | Young Adults
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents
Cohort Study
Karlstad Ø, Hovi P, Husby A, et al.
JAMA Cardiology
Published 2022
COVID-19 Vaccines | Myocarditis | Pericarditis | mRNA Vaccines | Young Males
FDA COVID-19 Vaccine Regulatory Review Documents
Regulatory Evidence Review
U.S. Food and Drug Administration
COVID-19 Vaccines | Pfizer-BioNTech | Moderna | Safety | Efficacy | Regulatory Review
Vaccine Adverse Event Reporting System (VAERS)
Centers for Disease Control and Prevention and U.S. Food and Drug Administration
Vaccine Safety | Adverse Event Reporting | Pharmacovigilance
Vaccine Safety Datalink (VSD)
Centers for Disease Control and Prevention and participating healthcare organizations
Vaccine Safety | Adverse Events | Signal Detection | Post-Licensure Surveillance
Christian Medical & Dental Associations
CMDA
Sanctity of Life | Beginning of Life | End-of-Life Ethics | Medical Ethics
American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG)
AAPLOG
Prenatal Human Life | Abortion | Maternal Health | Medical Ethics
Declaration of Helsinki
World Medical Association
Human Research | Medical Ethics | Informed Consent
The Belmont Report
U.S. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research
Published 1979
Research Ethics | Informed Consent | Human Subjects